Clinical Trial Update: Tocilizumab in Cardiac Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tocilizumab in heart transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Drugs mentioned

• Actemra (tocilizumab)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Heart Transplant | Phase 2 | Status: COMPLETED